Citations |
1. McGovern NN, Cowburn AS, Porter L, Walmsley SR, Thompson AAR, et al. Hypoxia Selectively Inhibits Respiratory Burst Activity and Killing of Staphylococcus aureus in Human Neutrophils. J Immunol. 2011,186:453–463. 2. De Boeck A., et al. Differential secretome analysis of cancer-associated fibroblasts and bone marrow-derived precursors to identify microenvironmental regulators of colon cancer progression. Proteomics. 2013 Jan,13(2):379-88. doi: 10.1002/pmic.201200179. Epub 2013 Jan 6. 3. Farahi N,Cowburn A S,Upton P D, Deighton J, Sobolewski A,et al.Eotaxin-1/CC Chemokine Ligand 11: A Novel Eosinophil Survival Factor Secreted by Human Pulmonary Artery Endothelial Cells. J Immunol. 2007,179:1264–1273 4. Sze S, Kleijn D, Lai R, Tan E, Zhao H,et al.Elucidating the Secretion Proteome of Human Embryonic Stem Cell-derived Mesenchymal Stem Cells.Mol Cell Proteomics. 2007, 6: 1680-1693 5. Xu Y, Ganem D. Induction of chemokine production by latent Kaposi's sarcoma-associated herpesvirus infection of endothelial cells. J Gen Virol. 2007,88:45-50. 6. Durand S H, Flacher V, Romeas A, Carrouel F,Colomb E,et al.Lipoteichoic Acid Increases TLR and Functional Chemokine Expression while Reducing Dentin Formation in In Vitro Differentiated Human Odontoblasts.J Immunol, 2006, 176: 2880-2887 7. Bingera T, Sticha S, Andreasa K, Kapsb C, Sezerc O,et al. Migration potential and gene expression profile of human mesenchymal stem cells induced by CCL25. Exp Cell Res. 2009,315:1468-1479 8. Hsu M, Wu S, Chang S, Su I, Tsai C,et al.Epstein-Barr Virus Lytic Transactivator Zta Enhances Chemotactic Activity through Induction of Interleukin-8 in Nasopharyngeal Carcinoma Cells. J. Virol. April 2008 vol. 82 no. 7 3679-3688 9. Rizzo M., et al. Low Molecular Weight Hyaluronan-Pulsed Human Dendritic Cells Showed Increased Migration Capacity and Induced Resistance to Tumor Chemoattraction. PLOS One, Published: September 19, 2014. DOI: 10.1371/journal.pone.0107944 |
Similar products |
CCL28, CXCL16, CTACK, BLC / CXCL13, Ck beta 8-1 / CCL23, ENA-78 / CXCL5, Eotaxin-1 / CCL11, Eotaxin-2 / CCL24, Eotaxin-3 / CCL26, Fractalkine / CX3CL1, GCP-2 / CXCL6, GRO / CXCL1+2+3, GRO alpha / CXCL1, HCC-4 / CCL16, I-309 / CCL1, I-TAC / CXCL11, IL-8 / CXCL8, IP-10 / CXCL10, Lymphotactin / XCL1, MCP-1 / CCL2, MCP-2 / CCL8, MCP-3 / CCL7, MCP-4 / CCL13, MDC / CCL22, MIG / CXCL9, MIP-1 alpha / CCL3, MIP-1 beta / CCL4, MIP-1 delta / CCL15, MIP-3 alpha / CCL20, MIP-3 beta / CCL19, MPIF-1 / CCL23, NAP-2 / CXCL7 / PPBP, PARC / CCL18, RANTES / CCL5, SDF-1 alpha / CXCL12alpha, SDF-1 beta / CXCL12beta, TARC / CCL17, TECK / CCL25 |
Targets Detected |
BLC, CCL1, CCL11, CCL13, CCL15, CCL16, CCL17, CCL18, CCL19, CCL2, CCL20, CCL22, CCL23, CCL24, CCL25, CCL26, CCL27, CCL28, CCL3, CCL4, CCL5, CCL7, CCL8, CK beta 8-1, CTACK, CX3CL1, CXCL1, CXCL10, CXCL11, CXCL12 alpha, CXCL12 beta, CXCL13, CXCL16, CXCL5, CXCL6, CXCL7, CXCL8, CXCL9, ENA-78, Eotaxin-1, Eotaxin-2, Eotaxin-3, Fractalkine, GCP-2, GRO, GRO alpha, HCC-4, I-309, I-TAC, IL-8, IP-10, Lymphotactin, MARC, MCP-1, MCP-2, MCP-3, MCP-4, MDC, MEC, MIG, MIP-1 alpha, MIP-1 beta, MIP-1 delta, MIP-3 alpha, MIP-3 beta, MPIF-1, MPIF-2, NAP-2, PARC, PPBP, RANTES, SDF-1 alpha, SDF-1 beta, TARC, TCA-3, TCK-1, TECK, XCL1 |